You are on page 1of 2

7280 Federal Register / Vol. 70, No.

28 / Friday, February 11, 2005 / Notices

Division Of Extramural Activities, National Contact Person: Harold L. Watson, PhD, Contact Person: Harold L. Watson, PhD,
Cancer Institute, National Institutes Of Scientific Review Administrator, Office of Scientific Review Administrator, Office of
Health, 6116 Executive Boulevard, Room Review, NCRR, National Institutes of Health, Review, NCRR, National Institutes of Health,
8057, MSC 8329, Bethesda, MD 20892–8329, 6701 Democracy Boulevard, 1 Democracy 6701 Democracy Boulevard, Room 1070,
(301) 496–7421, kerwinm@mail.nih.gov. Plaza, Room 1070, MSC 4874, Bethesda, MD MSC 4874, Bethesda, MD 20892–4874. (301)
20892–4874, (301) 435–0813, 435–0813. watsonh@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
watsonh@mail.nih.gov. (Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine;
Research; 93.394, Cancer Detection and Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical
Diagnosis Research; 93.395, Cancer 93.333, Clinical Research; 93.371, Biomedical Technology; 93.389, Research Infrastructure,
Treatment Research; 93.396, Cancer Biology Technology; 93.389, Research Infrastructure, 93.306, 93.333, National Institutes of Health,
Research; 93.397, Cancer Centers Support; 93.306, 93.333, National Institutes of Health, HHS)
93.398, Cancer Research Manpower; 93.399, HHS) Dated: February 4, 2005.
Cancer Control, National Institutes of Health, Dated: February 4, 2005. LaVerne Y. Stringfield,
HHS)
LaVerne Y. Stringfield, Director, Office of Federal Advisory
Dated: February 4, 2005. Director, Office of Federal Advisory Committee Policy.
LaVerne Y. Stringfield, Committee Policy. [FR Doc. 05–2650 Filed 2–10–05; 8:45 am]
Director, Office of Federal Advisory [FR Doc. 05–2647 Filed 2–10–05; 8:45 am] BILLING CODE 4140–01–M
Committee Policy.
BILLING CODE 4140–01–M
[FR Doc. 05–2646 Filed 2–10–05; 8:45 am]
BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND
DEPARTMENT OF HEALTH AND HUMAN SERVICES
HUMAN SERVICES
DEPARTMENT OF HEALTH AND National Institutes of Health
HUMAN SERVICES National Institutes of Health
National Center for Research
National Institutes of Health National Center for Research Resources; Notice of Closed Meetings
Resources; Notice of Meeting
National Center for Research Pursuant to section 10(d) of the
Resources; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as
Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice
Pursuant to section 10(d) of the amended (5 U.S.C. Appendix 2), notice is hereby given of the following
Federal Advisory Committee Act, as is hereby given of the following meetings.
amended (5 U.S.C. Appendix 2), notice meeting. The meetings will be closed to the
is hereby given of the following The meeting will be open to the public in accordance with the
meetings. public as indicated below, with provisions set forth in sections
The meetings will be closed to the attendance limited to space available. 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
public in accordance with the Individuals who plan to attend and as amended. The grant applications and
provisions set forth in sections need special assistance, such as sign the discussions could disclose
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., language interpretation or other confidential trade secrets or commercial
as amended. The grant applications and reasonable accommodations, should property such as patentable material,
the discussions could disclose notify the Contact Person listed below and personal information concerning
confidential trade secrets or commercial in advance of the meeting. individuals associated with the grant
property such as patentable material, The meeting will be closed to the applications, the disclosure of which
and personal information concerning public in accordance with the would constitute a clearly unwarranted
individuals associated with the grant provisions set forth in sections invasion of personal privacy.
applications, the disclosure of which 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Name of Committee: National Center for
would constitute a clearly unwarranted as amended. The grant applications and Research Resources Special Emphasis Panel,
invasion of personal privacy. the discussions could disclose Scientific and Technical Review Board.
Name of Committee: National Center for confidential trade secrets or commercial Date: March 24, 2005.
Research Resources Special Emphasis Panel. property such as patentable material, Time: 9 a.m. to adjournment.
Date: March 16, 2005. and personal information concerning Agenda: To review and evaluate grant
Time: 8 a.m. to Adjournment. individuals associated with the grant applications.
Agenda: To review and evaluate grant applications, the disclosure of which Place: Office of Review, Bethesda, MD
applications. would constitute a clearly unwarranted 20892. (Telephone conference call.)
Place: Double Tree Hotel, Rockville; 1750 Contact Person: Sheryl K. Brining, PhD,
Rockville Pike, Rockville, MD 20852.
invasion of personal privacy. Director, Office of Review, NCRR, National
Contact Person: Harold L. Watson, PhD, Name of Committee: National Center for Institutes of Health, 6701 Democracy Blvd, 1
Scientific Review Administrator, Office of Research Resources Initial Review Group, Democracy Plaza, Room 1074, MSC 4874,
Review, NCRR, National Institutes of Health, Research Centers in Minority Institutions Bethesda, MD 20892–4874. (301) 435–0809.
6701 Democracy Blvd., Room 1078, Review Committee. sb44k@nih.gov.
Bethesda, MD 20892, (301) 435–0813, Date: March 15, 2005. Name of Committee: National Center for
watsonh@mail.nih.gov. Open: 8 a.m. to 9 a.m. Research Resources Special Emphasis Panel.
Name of Committee: National Center for Agenda: To discuss program planning and Date: May 24–25, 2005.
Research Resources Special Emphasis Panel. other matters. Closed: May 24, 2005, 8 a.m. to
Date: April 4, 2005. Place: Double Tree Hotel, Rockville, 1750 adjournment.
Time: 8 a.m. to Adjournment. Rockville Pike, Rockville, MD 20852. Agenda: To review and evaluate grant
Agenda: To review and evaluate grant Closed: 9 a.m. to adjournment. applications.
applications. Agenda: To review and evaluate grant Place: Double Tree Hotel, Rockville, 1750
Place: NCRR, OR, 6701 Democracy Blvd., applications. Rockville Pike, Rockville, MD 20852.
Rockville, MD 20892 (Telephone Conference Place: DoubleTree Hotel, 1750 Rockville Contact Person: Carol Lambert, PhD,
Call). Pike, Rockville, MD 20852. Scientific Review Administrator, Office of

VerDate jul<14>2003 17:18 Feb 10, 2005 Jkt 205001 PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 E:\FR\FM\11FEN1.SGM 11FEN1
Federal Register / Vol. 70, No. 28 / Friday, February 11, 2005 / Notices 7281

Review, National Center for Research Closed: 7 p.m. to 9:30 p.m. The meetings will be closed to the
Resources, National Institute of Health, 6701 Agenda: Program Planning. public in accordance with the
Democracy Boulevard, 1 Democracy Plaza, Place: Hyatt Regency Bethesda, One provisions set forth in sections
Room 1076, Bethesda, MD 20892–4874. (301) Bethesda Metro Center, 7400 Wisconsin
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
435–0814. lambert@mail.nih.gov. Avenue, Bethesda, MD 20814.
Contact Person: Lore Anne McNicol, PhD, as amended. The grant applications and
(Catalogue of Federal Domestic Assistance the discussions could disclose
Program Nos. 93.306, Comparative Medicine; Director, Division of Extramural Research,
National Eye Institute, National Institutes of confidential trade secrets or commercial
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure, Health, Bethesda, MD 20892. property such as patentable material,
93.306, 93.333, National Institutes of Health, This notice is being published less than 15 and personal information concerning
HHS.) days prior to the meeting due to the timing individuals associated with the grant
limitations imposed by the review and applications, the disclosure of which
Dated: February 4, 2005. funding cycle. would constitute a clearly unwarranted
LaVerne Y. Stringfield, Information is also available on the
invasion of personal privacy.
Director, Office of Federal Advisory Institute’s/Center’s home page: http://
Committee Policy. www.nei.nih.gov, where an agenda and any Name of Committee: National Institute on
[FR Doc. 05–2651 Filed 2–10–05; 8:45 am] additional information for the meeting will Drug Abuse Special Emphasis Panel, Member
be posted when available. Conflict.
BILLING CODE 4140–01–M
(Catalogue of Federal Domestic Assistance Date: March 1–2, 2005.
Program Nos. 93.867, Vision Research, Time: 3 p.m. to 1 p.m.
DEPARTMENT OF HEALTH AND National Institutes of Health, HHS) Agenda: To review and evaluate grant
HUMAN SERVICES Dated: February 4, 2005. applications.
Place: Hyatt Regency Bethesda, One
LaVerne Y. Stringfield,
National Institutes of Health Bethesda Metro Center, 7400 Wisconsin
Director, Office of Federal Advisory Avenue, Bethesda, MD 20814.
Committee Policy. Contact Person: Rita Liu, PhD, Associate
National Eye Institute; Notice of
Meeting [FR Doc. 05–2652 Filed 2–10ndash;05; 8:45 Director, OEA, Office of Extramural Affairs,
am] National Institute on Drug Abuse, NIH,
Pursuant to section 10(d) of the BILLING CODE 4140–01–M′ DHHS, Room 212, MSC 8401, 6101 Executive
Federal Advisory Committee Act, as Boulevard, Bethesda, MD 20892–8401, (301)
amended (5 U.S.C. Appendix 2), notice 435–1388.
is hereby given of a meeting of the DEPARTMENT OF HEALTH AND
Name of Committee: National Institute on
National Advisory Eye Council. HUMAN SERVICES Drug Abuse Special Emphasis Panel, Member
The meeting will be opened to the Conflict Meeting.
public as indicated below, with National Institutes of Health
Date: March 9, 2005.
attendance limited to space available. Time: 3 p.m. to 4 p.m.
Individuals who plan to attend and National Heart, Lung, and Blood
Institute; Amended Notice of Meeting Agenda: To review and evaluate grant
need special assistance, such as sign applications.
language interpretation or other Notice is hereby given of a change in Place: Residence Inn Bethesda, 7335
reasonable accommodations, should the meeting of the Clinical Trials Wisconsin Avenue, Bethesda, MD 20814.
notify the Contact Person listed below Review Committee, February 28, 2005, 8 Contact Person: Mark Swieter, PhD, Health
in advance of the meeting. a.m. to March 2, 2005, 5 p.m., Sheraton Scientist Administrator, Office of Extramural
The meeting will be closed to the Inner Harbor Hotel, 300 South Charles Affairs, National Institute on Drug Abuse,
public in accordance with the Street, Baltimore, MD 21201 which was National Institutes of Health, DHHS, 6101
provisions set forth in sections published in the Federal Register on Executive Boulevard, Suite 220, Bethesda,
552b(c)(4) and 552b(c)(6), title 5 U.S.C., February 1, 2005, FR70:5191. MD 20892–8401, (301) 435–1389,
as amended. The grant applications and The meeting will start on February 27 ms80x@nih.gov.
the discussions could disclose at 6 p.m. and continue through March Name of Committee: National Institute on
confidential trade secrets or commercial 1, 2005. The meeting is closed to the Drug Abuse Special Emphasis Panel, Member
property such as patentable material, public. Conflict Meeting.
and personal information concerning Dated: February 4, 2005. Date: March 9, 2005.
individuals associated with the grant Time: 4 p.m. to 5 p.m.
LaVerne Y. Stringfield,
applications, the disclosure of which Agenda: To review and evaluate grant
would constitute a clearly unwarranted Director, Office of Federal Advisory applications.
Committee Policy. Place: Residence Inn Bethesda, 7335
invasion of personal privacy.
[FR Doc. 05–2656 Filed 2–10–05; 8:45 am] Wisconsin Avenue, Bethesda, MD 20814.
Name of Committee: National Advisory
Eye Council.
BILLING CODE 4140–01–M Contact Person: Mark Swieter, PhD, Health
Date: February 28, 2005. Scientist Administrator, Office of Extramural
Time: 10 a.m. to 12 p.m. Affairs, National Institute on Drug Abuse,
Agenda: Following opening remarks by the DEPARTMENT OF HEALTH AND National Institutes of Health, DHHS, 6101
Director, NEI, there will be presentations by HUMAN SERVICES Executive Boulevard, Suite 220, Bethesda,
the staff of the Institute and discussions MD 20892–8401, (301) 435–1389,
concerning Institute programs and policies. National Institutes of Health ms80x@nih.gov.
Place: Hyatt Regency Bethesda, One
National Institute on Drug Abuse; (Catalogue of Federal Domestic Assistance
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814. Notice of Closed Meetings Program Nos. 93.277, Drug Abuse Scientist
Closed: 1:30 p.m. to 5 p.m. Development Award for Clinicians, Scientist
Agenda: To review and evaluate grant Pursuant to section 10(d) of the Development Awards, and Research Scientist
applications. Federal Advisory Committee Act, as Awards; 93.278, Drug Abuse National
Place: Hyatt Regency Bethesda, One amended (5 U.S.C. Appendix 2), notice Research Service Awards for Research
Bethesda Metro Center, 7400 Wisconsin is hereby given of the following Training; 93.279, Drug Abuse Research
Avenue, Bethesda, MD 20814. meetings. Programs, National Institutes of Health, HHS)

VerDate jul<14>2003 17:18 Feb 10, 2005 Jkt 205001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\11FEN1.SGM 11FEN1

You might also like